Skip to content

Clinical trials

Adenocarcinoma trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Country / region: Austria Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20102
20121
20141
20151
20163
20211
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Active, not recruiting1
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott1
Ariad Pharmaceuticals1
AstraZeneca1
Australasian Gastro-Intestinal Trials Group1
Austrian Breast & Colorectal Cancer Study Group1
Boehringer Ingelheim1
Celgene1
EMD Serono Research & Development Institute, Inc.1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma13
Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Carcinoma3
Digestive System Diseases3
Digestive System Neoplasms3
Neoplasms by Site3
Pancreatic Neoplasms3
Carcinoma, Large Cell2
Carcinoma, Squamous Cell2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.